Real-world outcomes of consolidative radiotherapy following first-line chemo-immunotherapy in metastatic non-small cell lung cancer: a retrospective cohort study
American Journal of Cancer Research · 2026 · 16 (3) · 1070-1080
DOI: 10.62347/ucrc1869 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift American Journal of Cancer Research, 2026. Verfasst von Zhian Qiao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy, Xingtai People's Hospital Xingtai, Hebei, China. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiotherapy, Xingtai People's Hospital Xingtai, Hebei, China.
Zitieren
APA
Qiao, Z., Pang, L., & Zheng, H. (2026). Real-world outcomes of consolidative radiotherapy following first-line chemo-immunotherapy in metastatic non-small cell lung cancer: a retrospective cohort study. American Journal of Cancer Research, 16(3), 1070-1080. https://doi.org/10.62347/ucrc1869
Vancouver
Qiao Z, Pang L, Zheng H. Real-world outcomes of consolidative radiotherapy following first-line chemo-immunotherapy in metastatic non-small cell lung cancer: a retrospective cohort study. American Journal of Cancer Research. 2026;16(3):1070-1080. doi:10.62347/ucrc1869
BibTeX
@article{Qiao2026,
author = {Qiao, Zhian and Pang, Lin and Zheng, Hongxin},
title = {Real-world outcomes of consolidative radiotherapy following first-line chemo-immunotherapy in metastatic non-small cell lung cancer: a retrospective cohort study},
journal = {American Journal of Cancer Research},
year = {2026},
volume = {16},
number = {3},
pages = {1070--1080},
doi = {10.62347/ucrc1869}
}
EUVIMED